NSEAcquisition1d ago · 17 Sept 2026, 05:27 pm
Acquisition
Sandur Manganese & Iron Ores Limited · SANDUMA
✦ AI SummaryExpansion
Sandur Manganese & Iron Ores Limited has informed the Exchange about approval for incorporation of Wholly Owned Subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandur Manganese & Iron Ores Limited has informed the Exchange about approval for incorporation of Wholly Owned Subsidiary
Attachments (1)
📄pdf
Download →
SANDUR_17092026172357_Ltr2SEsToBeIncorpWOS.pdf
View document text
(An ISO 9001:2015; ISO 14001:2015 and ISO 45001:2018 certified company)
CIN: L85110KA1954PLC000759; Website: www.sandurgroup.com
Email ID: secretarial@sandurgroup.com
REGISTERED OFFICE CORPORATE OFFICE
‘SATYALAYA’, No.266 ‘SANDUR HOUSE’, No.9
Ward No.1, Palace Road Bellary Road, Sadashivanagar
Sandur – 583 119, Ballari District Bengaluru – 560 080
Karnataka, India Karnataka, India
Tel: 08395 260300 Tel: 080 4152 0176 - 79 / 4547 3000
SMIORE / SEC / 2026-27 / 47 17 September 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra-Kurla Complex
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 504918 Symbol: SANDUMA
Symbol: SANDUMA
Dear Sir/ Madam,
Sub: Approval for incorporation of Wholly Owned Subsidiary
Ref: Letter No. SMIORE / SEC / 2026-27 / 19 dated 9 July 2026 pertaining to venturing into new
lines of business of the Company
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) “SEBI (LODR)” Regulations, 2015, this is to inform Stock
Exchanges that the Board of Directors of the Company at its 387th meeting held today i.e., 17 September
2026 which commenced at 4:30 P.M. and concluded at 5:00 P.M., has approved the incorporation of a
Wholly Owned Subsidiary under the name and style of ‘Royal Sandur MedTech Private Limited’,
subject to necessary approvals.
Detailed information as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 in respect of the same is given in
‘Annexure A’ to this letter.
Stock Exchanges are requested to kindly take the same on record.
Thank you
for The Sandur Manganese & Iron Ores Limited
Neha Thomas
Company Secretary & Compliance Officer
ICSI Membership No. A60853
Encl: A/a
MINES OFFICE: Deogiri - 583112, Sandur Taluk, Ballari District; Tel: +91 8395 271028
PLANT OFFICE: Metal & Ferroalloy Plant, Vyasankere, Mariyammanahalli – 583 222, Hosapete Taluk, Vijayanagara District;
Tel: +91 8394 294802 / 805
Page 1 of 2
The Sandur Manganese & Iron Ores Limited
Annexure A
[Details as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026]
Name of the entity, date & country of Name: Royal Sandur MedTech Private Limited
incorporation, etc. Date: The Company is yet to be incorporated
Country of Incorporation: India
Name of holding company of the to Holding Company: The Sandur Manganese & Iron Ores
be incorporated company and Limited
relation with the listed entity
Relation: Wholly Owned Subsidiary of The Sandur
Manganese & Iron Ores Limited
Industry to which the entity being Medical devices and consumables manufacturing
incorporated belongs
Brief background about the entity Royal Sandur MedTech Private Limited will be
incorporated in terms of products/ incorporated to carry on the business of medical devices
line of business and consumables manufacturing including but not limited
to manufacturing, processing, assembling, marketing and
distribution of medical devices, surgical products,
diagnostic products and healthcare consumables.
Brief details of any governmental or Royal Sandur MedTech Private Limited will be
regulatory approvals required for incorporated subject to applicable laws and regulatory
the incorporation approvals, as required.
Nature of consideration - whether Subscription of equity shares in cash
cash consideration or share swap and
details of the same
Cost of subscription/ price at which 10,00,000 equity shares of ₹10/- each aggregating to
the shares are subscribed ₹1,00,00,000/-
Percentage of shareholding/ control 100%
by the listed entity and/ or number of
shares allotted
Page 2 of 2